How might an unmet patient need in metal health concerning memory be satisfied using transcribed session summaries

心理健康状况不佳是我们面临的最大健康问题。历史上的耻辱、对隐私的担忧和无知导致了系统性的研究资金不足，阻碍了创新。因此，缺乏一致的系统数据作为研究和开发新方法（如人工智能技术）的基础。coopts的产品Sylvie是一种潜在的解决方案，可以改善心理健康治疗。在Aster基金会的帮助下，Co-Opts发现，服务使用者以及接受心理健康治疗的服务使用者的朋友和家人认为Sylvie可以改善他们对心理健康治疗的体验。Sylvie最初的工作重点是帮助临床医生提高工作效率。服务用户获得的数据只是GDPR影响的副产品。这个项目的重点是从服务用户和临床医生的角度，使用设计思维和用户参与来检查将Sylvie作为心理健康治疗的一部分的影响。我们将探讨这两组用户的三个关键问题：1。器械的设计选择（如形状、大小、颜色、图案和硬件特征）对治疗联盟的影响，目的是设计一种设备，最大限度地减少对该联盟的影响。如何在不限制数据使用方式的情况下，将来自一个会话的数据呈现给两个组。我们发现，服务用户及其家人/朋友创造性地提出了各种可能使用数据的方法和方式，远远超出了我们对样本量的预期。一个关键的设计目标是鼓励这种适应。同样明显的是，随着治疗的进展，服务使用者可能更喜欢不同的表述。临床医生也可能希望根据不同的因素（如治疗点、目标等），以不同的方式向服务用户呈现一段时间以来的治疗数据。数据如何随时间呈现。这一点很重要，因为服务用户恢复的动机可能是决定结果的最关键因素。我们的研究表明，对于服务用户来说，能够看到Sylvie的进步对于保持动力很重要，尤其是在糟糕的会话之后。我们希望从这个项目中获得的设计、思考、学习和经验教训将在未来很好地为我们服务，因为我们不希望这是一次一次性的练习，而是成为公司与服务用户和临床医生合作的一个组成部分。

Poor mental health is the biggest health problem we face. Historic stigma, privacy concerns and ignorance have resulted in systematic underfunding of research hampering innovation. Consequently, there is an absence of consistent systematic data on which to base research and exploit new approaches e.g., AI techniques. Sylvie, Co-Opts product, is a potential solution that can improve mental health therapies.Co-Opts, with the help from the Aster Foundation, found that service-users, as well as friends and family of service-users in mental health therapies, thought that Sylvie could improve their experience of mental health therapies.Sylvie's initial focus was on helping clinicians' productivity. Service-users were getting the data only as a by-product of GDPR implications. This project's focus is to use design-thinking and user engagement to examine the implications of using Sylvie as part of mental health therapy from service-users and clinicians' perspective. We will explore three key issues with these two groups of users:1. The impact of design choices on the device (e.g. shape, size, colour, patterns and hardware features) on the therapeutic alliance, with the aim to design a device that minimises any impact on this alliance.2. How to present the data from one session to both groups without limiting ways of using the data. We have found that service-users and their family/friends creatively suggested a wide range of approaches and ways they might use the data, far more than we expected for the sample size. A key design objective is to encourage this adaptation. It is also clear that as treatment progresses service-users may prefer different presentations. Clinicians may also wish to present treatment data over time to the service user in different ways, depending on various factors (e.g. treatment points, goals, etc.).3. How the data might be presented through time. This is important because the service-user's motivation to recover is perhaps the most critical factor in determining outcomes. Our research suggests that being able to see the progress on Sylvie is important for maintaining motivation, particularly after poor sessions, for service-users.We expect that the design, thinking, learning, and lessons we will take from this project will serve us well into the future as we do not expect this to be a one-off exercise, but rather become an integral part of the company's engagement with service-users and clinicians.